NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $461 | -6.7% | 4,521 | -7.6% | 0.07% | -1.4% |
| Q2 2023 | $494 | +3.8% | 4,893 | -5.4% | 0.07% | -1.3% |
| Q1 2023 | $476 | -5.7% | 5,173 | -7.2% | 0.08% | -10.7% |
| Q4 2022 | $505 | -99.9% | 5,572 | -1.8% | 0.08% | +3.7% |
| Q3 2022 | $431,000 | -10.2% | 5,673 | 0.0% | 0.08% | -5.8% |
| Q2 2022 | $480,000 | +80.5% | 5,673 | +87.4% | 0.09% | +83.0% |
| Q1 2022 | $266,000 | -63.8% | 3,028 | -64.0% | 0.05% | -66.4% |
| Q4 2021 | $735,000 | +25.9% | 8,402 | +17.7% | 0.14% | +14.8% |
| Q3 2021 | $584,000 | -3.6% | 7,139 | +7.4% | 0.12% | -6.9% |
| Q2 2021 | $606,000 | +16.8% | 6,647 | +9.4% | 0.13% | +6.5% |
| Q1 2021 | $519,000 | -2.3% | 6,077 | +8.2% | 0.12% | -5.4% |
| Q4 2020 | $531,000 | +61.4% | 5,619 | +40.8% | 0.13% | +26.2% |
| Q1 2020 | $329,000 | -99.9% | 3,991 | +49.8% | 0.10% | -49.0% |
| Q4 2014 | $246,852,000 | +78017.7% | 2,664 | -32.3% | 0.20% | -24.9% |
| Q4 2013 | $316,000 | – | 3,933 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |